The CRUK Convergence Science Centre is a partnership between Imperial College London and The Institute of Cancer Research (ICR). We bring together researchers across these institutions from different disciplines to develop innovative ways to address challenges in cancer research and improve patient outcomes.
The Science in Medicine School Teams Prize 2025 is a competition for sixth form students in science in medicine. The CRUK Convergence Science Centre is supporting one of the contests, asking students to develop an idea using science or technology to make the patient experience of cancer treatment more supportive or comforting. Students will have the opportunity to explore the science behind current cancer treatments and use their creativity to come up with novel ideas in true convergence style!
Precision medicine and the use of data in cancer research: Highlights from our 2025 annual symposium
Catch up on the highlights from our 2025 Annual Symposium which focussed on 'Precision medicine and the use of data in cancer research'.
New Publication: New potential drug for treatment resistant prostate cancer
Through the support of the Centre, a new drug, known as NXP800, has been identified by researchers at the ICR as a potential treatment for hard-to-treat prostate cancers that are resistant to hormone therapy. This research shows how bridging clinical observations and discovery research through convergence science can rapidly offer new treatment options for hard-to-treat cancers.
